BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

692 related articles for article (PubMed ID: 16551286)

  • 21. Beta-2-microglobulin amyloidosis and renal bone disease.
    Drüeke TB
    Miner Electrolyte Metab; 1991; 17(4):261-72. PubMed ID: 1813789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Beta 2-microglobulin-induced amyloidosis. A new complication of long-term hemodialysis].
    Ritz E; Bommer J; Zeier M
    Dtsch Med Wochenschr; 1988 Feb; 113(5):190-6. PubMed ID: 3276494
    [No Abstract]   [Full Text] [Related]  

  • 23. [Morphology and diagnosis of hemodialysis--related amyloidosis].
    Ohashi K; Kawai R; Hara M
    Nihon Rinsho; 1992 Jan; 50 Suppl():801-6. PubMed ID: 1578770
    [No Abstract]   [Full Text] [Related]  

  • 24. Arthropathies associated with renal disease including dialysis-related amyloid.
    Ford PM
    Curr Opin Rheumatol; 1992 Feb; 4(1):63-7. PubMed ID: 1543664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein E and alpha 1-antichymotrypsin in dialysis-related amyloidosis.
    Gejyo F; Kimura H; Suzuki S; Miyazaki R; Naiki H; Nakakuki K
    Kidney Int Suppl; 1997 Nov; 62():S75-8. PubMed ID: 9350687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electron microscopic characteristics of beta2-microglobulin amyloid deposits in long-term haemodialysis.
    Bély M; Kapp P; Szabó TS; Lakatos T; Apáthy A
    Ultrastruct Pathol; 2005; 29(6):483-91. PubMed ID: 16316949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gastrointestinal involvement of dialysis-related amyloidosis.
    Takahashi S; Morita T; Koda Y; Murayama H; Hirasawa Y
    Clin Nephrol; 1988 Sep; 30(3):168-71. PubMed ID: 3052956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Amyloidosis in hemodialysis patients].
    Bardin T; Zingraff J; Benoît J; Kuntz D; Drüeke T
    Presse Med; 1987 May; 16(18):907-10. PubMed ID: 2954121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemodialysis-related amyloidosis: Is it still relevant?
    Kaneko S; Yamagata K
    Semin Dial; 2018 Nov; 31(6):612-618. PubMed ID: 29896815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Amyloidosis associated with chronic hemodialysis. The prognostic significance of beta 2-microglobulin changes in patients with terminal chronic kidney failure treated by repeated hemodialysis].
    Manasia M; Meseşan M; Gherman-Căprioară M; Malide D; Paţiu IM; Pârvu L; Vlăduţiu D; Spânu CS
    Med Interna; 1991; 43(1-2):129-34. PubMed ID: 1670118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Amyloidosis and renal failure].
    Musini S; Savazzi GM
    Recenti Prog Med; 1999 Oct; 90(10):530-5. PubMed ID: 10592739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dialysis-associated amyloid: systemic or local?
    Sethi D; Cary NR; Brown EA; Woodrow DF; Gower PE
    Nephrol Dial Transplant; 1989; 4(12):1054-9. PubMed ID: 2483747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pathogenesis of amyloidosis: a role for anti-proteases?].
    Argilés i Ciscart A; Mourad G
    Nephrologie; 1991; 12(2):51-4. PubMed ID: 1719439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dialysis-related amyloidosis.
    Bardin T; Zingraff J; Kuntz D; Drüeke T
    Nephrol Dial Transplant; 1986; 1(3):151-4. PubMed ID: 3110668
    [No Abstract]   [Full Text] [Related]  

  • 35. Historical background and clinical treatment of dialysis-related amyloidosis.
    Yamamoto S; Gejyo F
    Biochim Biophys Acta; 2005 Nov; 1753(1):4-10. PubMed ID: 16226497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis, pathogenesis, and treatment of dialysis-related amyloidosis.
    Miyata T; Inagi R; Kurokawa K
    Miner Electrolyte Metab; 1999; 25(1-2):114-7. PubMed ID: 10207272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of gastrointestinal beta2-microglobulin amyloidosis correlates with time on dialysis.
    Jimenez RE; Price DA; Pinkus GS; Owen WF; Lazarus JM; Kay J; Turner JR
    Am J Surg Pathol; 1998 Jun; 22(6):729-35. PubMed ID: 9630180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pathogenesis of dialysis amyloidosis].
    Gejyo F; Hasegawa S; Homma N; Maruyama H; Maruyama S; Arakawa M
    Nihon Rinsho; 1992 Jan; 50 Suppl():796-800. PubMed ID: 1578769
    [No Abstract]   [Full Text] [Related]  

  • 39. Amyloidosis and its impact on patients with ESRD.
    Copeland SD
    Nephrol Nurs J; 2006; 33(1):31-3; quiz 34-5. PubMed ID: 16538926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Amyloid deposits in hemodialysis patients: immunochemical analysis].
    Argiles A; Mourad G; Axelrud-Cavadore C; Cavadore JC; Mion C
    Nephrologie; 1987; 8(2):51-4. PubMed ID: 3302740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.